Scientists in the laboratory of Rendong Yang, Ph.D., associate professor of Urology, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more ...
HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...
A replay of the webcast will be available shortly after the conclusion of the call on the Investor Relations section of the Caris Life Sciences website at CarisLifeSciences.com. A ...
Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.
The gene fusion testing market offers opportunities in developing advanced technologies like next-generation sequencing (NGS) ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study in Nature's npj Breast Cancer journal titled, ...
The study of abiotic stress responses in non-model plants represents a rapidly emerging field that is vital to expanding the diversity and resilience of ...
Parse Biosciences introduces workflow for immune repertoire and transcriptome analysis: Seattle Saturday, January 24, 2026, 15:00 Hrs [IST] Parse Biosciences, the leading provider ...
Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood clotting. Antiphospholipid syndrome is best known for increasing the risk ...
Treating antiphospholipid syndrome by focusing on blood clots falls short of addressing the underlying biology driving each individual patient's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results